Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CuraGen Corporation.

Traci Mansfield1, Mark R Vincent

  • 1CuraGen Corporation, 555 Long Wharf Drive, New Haven, CT 06511, USA.

Pharmacogenomics
|August 8, 2002
PubMed
Summary
This summary is machine-generated.

CuraGen utilizes functional genomics and pharmacogenomics to advance drug discovery. This approach identifies potential safety and efficacy issues early, informing decisions on preclinical and clinical development for novel therapeutics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial.

Diabetes technology & therapeutics·2018
Same author

Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial.

Journal of diabetes·2015
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Area of Science:

  • Biotechnology
  • Genomics
  • Drug Discovery

Background:

  • Functional genomics and pharmacogenomics are crucial for modern drug development.
  • Early identification of safety and efficacy issues streamlines the therapeutic pipeline.

Purpose of the Study:

  • To describe CuraGen's integrated approach to drug discovery using functional genomics.
  • To highlight the role of pharmacogenomics in informed therapeutic development.

Main Methods:

  • Integration of molecular biology expertise with proprietary functional genomic technologies.
  • Application of pharmacogenomics to assess drug safety and efficacy.
  • Utilizing functional genomics to understand drug mechanisms of action.

Main Results:

Related Experiment Videos

  • Development of a robust preclinical pipeline for protein, antibody, and small molecule therapeutics.
  • Enhanced decision-making for advancing drug candidates through development stages.
  • Improved understanding of drug safety and efficacy profiles early in the discovery process.

Conclusions:

  • Functional genomics and pharmacogenomics are vital for efficient and informed drug discovery.
  • CuraGen's integrated approach accelerates the development of novel therapeutics.
  • Early-stage safety and efficacy assessments lead to better-informed preclinical and clinical decisions.